Ginkgo Bioworks Holdings DNA Income Statement (2020-2026)

NYSE DNA
$6.89 -0.06 (-0.86%)
As of: Sep 4, 2026 · 10:51 AM EDT
Reported Financials

Ginkgo Bioworks Holdings Quarterly Income Statement

Periods 24 quarters
Latest Jun 2026

Ginkgo Bioworks Holdings reported revenue of $20.16M and net income of -$57.32M for the quarter ended Jun 2026, down 48.5% year over year. This income statement covers 24 quarters of results from Sep 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
77.61M148.49M168.41M144.62M66.40M98.28M80.70M80.57M55.43M243.09M37.94M56.21M89.05M43.85M38.23M39.13M38.84M33.40M19.47M20.16M
Cost of RevenueCost of Rev
18.87M81.76M77.34M61.47M24.66M9.57M22.38M18.10M6.92M-0.87M9.20M11.81M9.99M7.55M4.09M5.38M8.18M5.95M3.10M1.72M
Gross Profit
58.74M66.73M91.07M83.15M41.74M88.71M58.33M62.47M48.51M243.96M28.74M44.40M79.06M36.29M34.14M33.75M30.66M27.45M16.38M18.44M
Operating items
Research & DevelopmentR&D
53.02M985.02M323.58M290.06M261.46M177.55M162.64M144.28M156.66M117.04M136.46M134.22M77.01M76.38M70.92M53.37M69.35M50.13M49.92M46.21M
Selling, General & AdministrativeSG&A
28.96M781.63M434.77M438.43M435.22M121.38M111.43M102.34M82.03M89.22M70.29M66.28M52.29M57.30M39.72M34.98M44.95M46.01M37.83M30.77M
Restructuring CostsRestructuring
17.07M2.95M4.16M4.50M3.60M1.75M0.71M
Other Operating ExpensesOther Opex
-4.91M-2.60M1.92M0.23M-0.68M6.16M2.93M3.22M2.89M0.09M2.02M-0.77M-7.01M10.88M-4.64M-1.17M-0.16M0.82M-7.15M0.81M
Operating ExpensesOpex
104.28M1,833.23M843.78M792.40M721.34M329.15M296.45M264.72M341.82M212.87M215.95M279.15M144.25M147.45M119.20M97.30M128.85M104.15M90.85M78.70M
Operating IncomeOp. Inc
-26.67M-1684.73M-675.37M-647.78M-654.94M-230.86M-215.75M-184.15M-286.39M-178.12M-178.00M-222.94M-55.20M-103.61M-80.97M-58.16M-90.02M-70.75M-71.37M-58.55M
EBIT
-26.67M-1684.73M-675.37M-647.78M-654.94M-230.86M-215.75M-184.15M-286.39M-178.12M-178.00M-222.94M-55.20M-103.61M-80.97M-58.16M-90.02M-70.75M-71.37M-58.55M
Non-operating items
Non Operating Interest Expenses
0.65M0.55M-14.35M-15.02M44.01M-10.31M-9.25M31.37M
Non Operating Investment IncomeNon-Op. Investment Inc.
-12.37M-14.55M0.45M-38.67M-1.76M-13.35M-6.37M-2.12M-36.32M-10.01M-2.54M-6.83M-6.91M-12.54M-3.69M-0.23M3.68M-16.17M-1.21M1.99M
Interest & Investment IncomeInt & Inv Inc
0.12M0.50M38.61M0.11M-0.08M0.32M22.28M-0.08M-0.21M
Other Non Operating IncomeOther Non Op Inc.
-75.94M79.06M82.59M-22.84M15.99M43.02M10.86M10.90M-16.52M-47.74M12.12M5.95M-1.57M-4.25M-2.25M4.69M9.26M-10.64M-4.76M1.35M
Net income details
EBT
-102.61M-1605.68M-592.78M-670.62M-670.16M-187.85M-204.89M-173.25M-302.91M-211.89M-165.88M-216.99M-56.78M-107.86M-83.22M-53.48M-80.75M-81.39M-76.14M-57.19M
Tax ProvisionsTaxes
-0.21M-0.68M-0.18M-0.04M-0.03M-14.77M0.08M0.07M-0.02M-0.20M0.03M0.19M-0.38M-0.33M0.09M-0.28M0.00M-0.64M-0.08M0.13M
Profit After TaxPAT
-102.41M-1606.71M-592.59M-670.57M-672.54M-167.80M-204.97M-173.31M-304.49M-211.43M-168.95M-217.35M-56.40M-109.60M-90.96M-60.30M-80.75M-80.75M-83.24M-57.32M
Equity Income
-39.65M-4.66M-20.89M-10.17M-22.71M10.00M-1.45M-0.07M-1.12M-4.67M
Income from Non-Controlling InterestsInc. Minority
-0.52M-4.34M-2.09M-1.75M2.39M
Income from Continuing OperationsIncome (Continuing)
-102.41M-1604.99M-592.59M-670.57M-670.13M-173.08M-204.97M-173.31M-302.89M-211.69M-165.91M-217.18M-56.40M-107.53M-83.31M-53.19M-80.75M-80.75M-76.06M-57.32M
Income from Discontinued OperationsIncome (Discontinued)
-7.65M-7.11M-6.53M10.61M
Consolidated Net IncomeConsol Net Inc.
-102.41M-1604.99M-592.59M-670.57M-670.13M-173.08M-204.97M-173.31M-302.89M-211.69M-165.91M-217.18M-56.40M-107.53M-90.96M-60.30M-80.75M-80.75M-82.59M-46.71M
Income towards Parent CompanyParent Net Inc
-102.41M-1604.99M-592.59M-670.57M-670.13M-173.08M-204.97M-173.31M-302.89M-211.69M-165.91M-217.18M-56.40M-107.53M-90.96M-60.30M-80.75M-80.75M-82.59M-46.71M
Net Income towards Common StockholdersNet Income
-102.41M-1604.99M-590.50M-670.57M-670.13M-173.08M-204.97M-173.31M-302.89M-211.69M-165.91M-217.18M-56.40M-107.53M-90.96M-60.30M-80.75M-80.75M-82.59M-46.71M
Additional items
EPS (Basic)
-3.09-47.21-14.69-16.55-16.44-4.12-4.28-3.59-6.21-4.35-3.31-4.23-1.08-2.07-1.68-1.10-1.45-1.46-1.39-0.75
EPS (Diluted)
-3.09-47.19-14.69-16.55-16.44-4.12-4.28-3.59-6.21-4.35-3.31-4.23-1.08-2.07-1.68-1.10-1.45-1.46-1.49-0.84
Shares Outstanding
33.09M34.00M40.19M40.52M40.77M41.98M47.87M48.34M48.77M48.61M50.11M51.37M52.24M51.89M54.24M54.86M55.63M55.46M59.56M62.09M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
33.09M34.01M40.19M40.52M40.77M42.00M47.92M48.34M48.77M48.61M50.13M51.38M52.25M51.89M54.24M54.86M55.63M55.46M55.46M55.46M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
37.17M77.41M40.55M40.89M41.21M84.43M48.35M48.87M49.32M50.03M50.84M51.97M53.08M54.37M54.70M55.43M56.84M58.21M61.66M63.71M
EBITDA
-26.67M-1684.73M-675.37M-647.78M-654.94M-230.86M-215.75M-184.15M-286.39M-178.12M-178.00M-222.94M-55.20M-103.61M-80.97M-58.16M-90.02M-70.75M-71.37M-58.55M
Interest ExpensesInt Expense
0.65M0.55M-14.35M-15.02M44.01M-10.31M-9.25M31.37M
Tax Rate
0.20%0.04%0.03%0.01%0.00%7.86%-0.04%-0.04%0.01%0.09%-0.02%-0.09%0.66%0.30%-0.11%0.53%0.00%0.79%0.11%-0.22%